Medicare is proposing across-the-board cuts to what Trump administration officials believe are overpriced medical procedures, ...

From my colleague Drew Joseph: Ahead of an advisory committee meeting Thursday focused on GSK’s multiple myeloma drug Blenrep, the FDA pointed to concerns about the high rates of eye issues that have ...